Alternatives to Biomica

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Biotechnology company developing novel therapies for multiple myeloma.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Developing novel therapeutic approaches for ocular diseases.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Drug discovery and development company using a novel technological approach.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Develops and commercializes a novel cancer treatment technology called Alpha DaRT.

CBX Therapeutics is a biotechnology company focused on developing novel therapies for cancer.

AI-driven digital twin of embryo development for cell-based therapies.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-driven platform for protein-level disease mapping and drug discovery.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Own Chemex.ai today. Secure checkout and guided transfer support. No hidden fees.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered insights platform for life sciences and biotech workflows.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

Compressing biology to develop the next generation of therapies.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Develops autologous engineered tissue from omentum biopsies for medical conditions.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Developing polymer-based nanoparticles for targeted gene therapy delivery.